Michael Y. Lin

2.8k citations

75 papers · 1.5k indexed · h-index 21

Impact in

Applied Microbiology and Biotechnology top 0.5%
- Antibiotic Use and Resistance
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 25
- Antibiotic Use and Resistance 25
Molecular Medicine 26
- Antibiotic Resistance in Bacteria 26

Co-authors: Robert A. Weinstein Mary K. Hayden Karen Lolans William E. Trick Bala Hota Nicholas M. Moore Michael Roth David M. Prescott
Journals: Infection Control and Hospital Epidemiology (19 papers)Open Forum Infectious Diseases (14 papers)Clinical Infectious Diseases (12 papers)The Journal of Physiology (2 papers)The Journal of Infectious Diseases (2 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

Michael Y. Lin

68 papers receiving 1.4k citations

Peers

Countries citing papers authored by Michael Y. Lin

Since Specialization

Citations

This map shows the geographic impact of Michael Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Y. Lin more than expected).

Fields of papers citing papers by Michael Y. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Y. Lin. The network helps show where Michael Y. Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Y. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Y. Lin Line = papers co-authored together Michael Y. Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishing a Practical Approach to Sewer Monitoring for Antimicrobial Resistance Genes and Organisms at Healthcare Facilities The Journal of Infectious Diseases ·Rachel Poretsky, David Reisman, Н.Н. Кравченко, Michael Schoeny, Soares da Silva Anderson Paulo, R. Balaišytė, Jaishree, P. Wagenbichler, Rafatul Haque Rishad, Erin Newcomer, Adit Chaudhary, 義弘坂口, 足立一樹, 鈴木健司, Amanda K. Lyons, Florence Whitehill, Mary K. Hayden, Stefan J. Green, Michael Y. Lin	2025	0
2	Impact of diagnostic stewardship on catheter-associated urinary tract infections and patient outcomes Infection Control and Hospital Epidemiology ·Sarah E. Sansom, Yonatan Christian Leonardi, Brian Stein, Michael Schoeny, L. Lee, Vehbi Neziri, Fadila Avdic-Kamberovic, Mary K. Hayden, Michael Y. Lin, John Segreti	2024	1
3	Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit Nature Medicine ·Anette Bodén, Evan S. Snitkin, Michael Y. Lin, Teppei Shimasaki, Michael Schoeny, Andreas Trotzke, 川島真一, Nicholas M. Moore, Sarah E. Sansom, Y. SHIBATA, L F Berkmann, Krishna Rao, Ping Tao, Barbara Bottazi, Christine M. Bassis, Mary K. Hayden, Vincent B. Young	2023	25
4	403. Strain Epidemiology of Clostridioides difficile across Three Geographically Distinct Medical Centers in Chicago Open Forum Infectious Diseases ·Do Young ‍Kim, Adam Cheknis, 寛文岡田, Michael Y. Lin, Mary K. Hayden, Nicholas M. Moore, M. A. Kosov, Vera Tešić, Kathleen G. Beavis, Dale N. Gerding, Stuart Johnson, Andrew M Skinner	2022	2
5	Regional Spread of bla NDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities Clinical Infectious Diseases ·Zena Lapp, Ryan Crawford, Anette Bodén, Ali Pirani, William E. Trick, Robert A. Weinstein, Mary K. Hayden, Evan S. Snitkin, Michael Y. Lin	2021	30
6	Cohorting KPC+ Klebsiella pneumoniae (KPC-Kp)–positive patients: A genomic exposé of cross-colonization hazards in a long-term acute-care hospital (LTACH) Infection Control and Hospital Epidemiology ·野田浩幸, Mary K. Hayden, Karen Lolans, Y. SHIBATA, Robert A. Weinstein, Michael Y. Lin, Evan S. Snitkin	2020	3
7	897. Prevalence of Candida auris at Body Sites, Characterization of Skin Microbiota, and Relation of Chlorhexidine Gluconate (CHG) Skin Concentration to C. auris Detection Among Patients at a High-Prevalence Ventilator-Capable Skilled Nursing Facility (vSNF) with Established CHG Bathing Open Forum Infectious Diseases ·Mary K. Hayden, 川島真一, Y. SHIBATA, Michael Schoeny, L F Berkmann, Mary Stanley, Nailliw Z. Preite, Nadia Khan, Kerlly Jhurlley Martinez Ortega, Stéphanie Black, Massimo Pacilli, Xin Huang, Clay Deming, Michael Y. Lin, Julia A. Segre	2019	6
8	Spread of Carbapenem-ResistantEnterobacteriaceaeAmong Illinois Healthcare Facilities: The Role of Patient Sharing Clinical Infectious Diseases ·Michael Ray, Michael Y. Lin, Robert A. Weinstein, William E. Trick	2016	45
9	Epidemiology of the β-Lactamase Resistome Among Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in the Chicago Region Open Forum Infectious Diseases ·Michael Y. Lin, Karen Lolans, Rosie D. Lyles, Eberle Alexander, G. Walker, Robert A. Weinstein, Mary K. Hayden	2015	2
10	Understanding Staff Perceptions about Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae Control Efforts in Chicago Long-Term Acute Care Hospitals Infection Control and Hospital Epidemiology ·Rosie D. Lyles, Nicholas M. Moore, Shayna Weiner, Monica K Sikka, Michael Y. Lin, Robert A. Weinstein, Mary K. Hayden, Ronda L. Sinkowitz‐Cochran	2014	7
11	Prevention of Colonization and Infection by Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in Long-term Acute-Care Hospitals Clinical Infectious Diseases ·Mary K. Hayden, Michael Y. Lin, Karen Lolans, Shayna Weiner, Donald Blom, Nicholas M. Moore, Louis Fogg, David B. Henry, Rosie D. Lyles, Henley M John Smart, Monica K Sikka, David Hines, Robert A. Weinstein	2014	136
12	Survey of Infection Prevention Informatics Use and Practitioner Satisfaction in US Hospitals Infection Control and Hospital Epidemiology ·Max Masnick, Daniel J. Morgan, Marc‐Oliver Wright, Michael Y. Lin, Lisa Pineles, Anthony D. Harris	2014	8
13	The Effectiveness of Routine Daily Chlorhexidine Gluconate Bathing in Reducing Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae Skin Burden among Long-Term Acute Care Hospital Patients Infection Control and Hospital Epidemiology ·Michael Y. Lin, Karen Lolans, Donald Blom, Rosie D. Lyles, Shayna Weiner, A. Twardowska, Nicholas M. Moore, David Hines, Robert A. Weinstein, Mary K. Hayden	2014	36
14	Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study Infection Control and Hospital Epidemiology ·Kavitha Prabaker, Michael Y. Lin, Margaret McNally, Kartikeya Cherabuddi, 张铁中, Izabela De Oliveira Trajano, Karen Lolans, Md. Imdad Islam, Vishnu Chundi, Robert A. Weinstein, Mary K. Hayden	2012	78
15	Anatomic Sites of Patent Colonization and Environmental Contamination with Klebsiella pneumoniae Carbapenemase—Producing Enterobacteriaceae at Long-Term Acute Care Hospitals Infection Control and Hospital Epidemiology ·Henley M John Smart, Kavitha Prabaker, Michael Y. Lin, Karen Lolans, Robert A. Weinstein, Mary K. Hayden	2012	38
16	Use of the point of origin code from a universal billing form, UB-04, to efficiently identify hospitalized patients admitted from other health care facilities American Journal of Infection Control ·Kavitha Prabaker, Mary K. Hayden, Robert A. Weinstein, Michael Y. Lin	2012	7
17	Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains Scandinavian Journal of Infectious Diseases ·Courtney Hebert, Zhi-Dong Shao, Jocelyn Tolentino, P. Mohanty, Sue Boonlayangoor, David Pitrak, Michael Y. Lin, Stephen G. Weber	2010	11
18	Classic pyomyositis of the extremities as an unusual manifestation ofBlastomyces dermatitidis: a report of two cases Mycoses ·Michael Y. Lin, Shingo Chihara, Kimberly Y. Smith, Harold A. Kessler, Beverly E. Sha, Laurie A. Proia	2009	2
19	Endocytosis and synaptic plasticity: might the tail wag the dog? Trends in Neurosciences ·Robert S. Wilkinson, Michael Y. Lin	2004	15
20	Standard Spacecraft Interfaces and IP Network Architectures: Prototyping Activities at the GSFC UA Campus Repository (The University of Arizona) ·R. Schnurr, M.K. Hite, Michael Y. Lin	2003	1

About Michael Y. Lin

Michael Y. Lin is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Epidemiology, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (26 papers), Antibiotic Use and Resistance (25 papers), Bacterial Identification and Susceptibility Testing (15 papers), Urinary Tract Infections Management (10 papers), Clostridium difficile and Clostridium perfringens research (10 papers), Patient Satisfaction in Healthcare (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Infection Control in Healthcare (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (420 citations), Molecular Medicine (561 citations), Clinical Biochemistry (316 citations), Endocrinology (163 citations) and Critical Care and Intensive Care Medicine (133 citations). Michael Y. Lin has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Robert A. Weinstein, Mary K. Hayden, Karen Lolans, William E. Trick, Bala Hota, Nicholas M. Moore, Michael Roth, David M. Prescott, Keith F. Woeltje and Louis Fogg. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, Clinical Infectious Diseases, The Journal of Physiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact